本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

RESONANCE HEALTH LTD

0.044
+0.0024.76%
成交量:45.79萬
成交額:2.05萬
市值:2,071.35萬
市盈率:-11.56
高:0.046
開:0.045
低:0.044
收:0.042
52周最高:0.068
52周最低:0.033
股本:4.71億
流通股本:2.96億
量比:2.37
換手率:0.15%
股息:- -
股息率:- -
每股收益(TTM):-0.004
每股收益(LYR):-0.004
淨資產收益率:-17.05%
總資產收益率:-5.19%
市淨率:2.21
市盈率(LYR):-11.56

資料載入中...

公司資料

公司名字:
RESONANCE HEALTH LTD
交易所:
ASX
成立時間:
1987
員工人數:
16
公司地址:
141 Burswood Road,Level 1,Burswood,Western Australia,Australia
郵編:
6100
傳真:
61 8 9286 5399
簡介:
Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship product is FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials, including clinical measurement, as well as project and data management services, such as reporting, administration, and support. The company serves clinicians for the diagnosis and management of human diseases; and pharmaceutical companies for their clinical trials. Resonance Health Limited is headquartered in Burswood, Australia.